Proteomics

Dataset Information

0

Mapping the complexity of ME/CFS: Evidence for abnormal energy metabolism, altered immune profile and vascular dysfunction


ABSTRACT: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder with no known underlying mechanisms, diagnostic tools, or treatments. Multiple areas of dysfunction have been extensively studied, but rarely examined together. We recruited age- and sex-matched ME/CFS patients and healthy controls for a multi-modal study examining energy metabolism, immune profiles and plasma protein levels. Adenosine monophosphate (AMP) were higher in immune cells from MECFS patients, with a similar but non-signficant trend observed in plasma. Additionally, immune cells showed higher levels of adenosine diphosphate (ADP) and a reduced adenosine triphosphate/adenosine diphosphate (ATP/ADP) ratio. These findings imply decreased ATP generation and the presence of energy stress within the immune cell population. Adaptive immune cell populations were skewed towards less mature effector subsets of CD4+, CD8+ and γδ T cells, and proportions of CD1c+CD141- conventional DC type 2 (cDC2) and CD56lowCD16+ terminal natural killer (NK) cells were also reduced. Elevated levels of plasma proteins associated with thrombus formation and vascular reactivity may contribute to the endothelial dysfunction observed in ME/CFS patients. Using Classification and Regression Tree (CART) modelling, we identified variables from each mode of investigation with strong predictive potential for ME/CFS. Together, this study provides new insights intothe somatic symptoms and underlying biology of ME/CFS.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Chronic Fatigue Syndrome

SUBMITTER: Shivani Krishnamurthy  

LAB HEAD: Dr. Benjamin Heng

PROVIDER: PXD068504 | Pride | 2025-11-14

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2020-11-05 | PXD019806 | Pride
2024-01-24 | GSE235103 | GEO
2025-01-29 | GSE246300 | GEO
| 2332975 | ecrin-mdr-crc
2025-12-02 | GSE280863 | GEO
2025-08-18 | GSE293840 | GEO
2015-06-08 | MTBLS161 | MetaboLights
2021-11-03 | PXD022350 | Pride
2018-07-23 | GSE111183 | GEO
2025-01-29 | GSE277725 | GEO